NCT02693548Recruiting
The Spanish Familial Hypercholesterolaemia Cohort Study
Source: ClinicalTrials.gov · Last updated 4 Sept 2026
Brief summary (registry, in English)
SAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4141 (estimated)
- First submitted
- 9 Feb 2016
- Start date
- Jan 2004
- Primary completion date
- Oct 2030
- Lead sponsor
- Fundación Hipercolesterolemia Familiar
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT02693548
What you commit to
- Study type: Observational
- Planned participants: 4141
- From Jan 2004 to the primary completion date, Oct 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient unwillingness
Who the study is looking for
- Index cases with genetic diagnosis of FH and their relatives over 15 years old with a genetic diagnosis of FH and their first-degree relatives
Age in the registry: 15 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fundacion Hipercolesterolemia Familiar Coordinator of this site? Confirm its status | Madrid | Spain | Recruiting |
Related publications
- Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study.Eur Heart J · 2026 · PMID 42290618
This page is information, not medical advice. Discuss any trial with your doctor.